{
  "retracted": false,
  "timestamp": 1546300800000,
  "updates": [
    {
      "timestamp": 1585035484529,
      "identifier": {
        "doi": "10.1016/j.clinbiochem.2018.10.005"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.clinbiochem.2018.08.012"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to ‘IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?’ Clinical Biochemistry 61 (2018) 34–39"
}
